Cover Image
市場調查報告書

全球避孕藥及避孕器市場趨勢、機會、分析、市場佔有率及預測

Global Contraceptive Drug & Devices Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 - 2022

出版商 Occams Business Research & Consulting Pvt. Ltd. 商品編碼 370295
出版日期 內容資訊 英文 140 Pages
商品交期: 請詢問到貨日
價格
Back to Top
全球避孕藥及避孕器市場趨勢、機會、分析、市場佔有率及預測 Global Contraceptive Drug & Devices Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 - 2022
出版日期: 2016年09月07日 內容資訊: 英文 140 Pages
簡介

本報告提供全球避孕藥及避孕器市場相關調查,市場概要和各市場區隔,各地區趨勢,競爭環境,及加入此市場的主要企業簡介等彙整資料。

第1章 簡介

第2章 市場概要

  • 市場定義和範圍
  • 主要調查結果
  • 指標分析
  • 主要的市場趨勢
  • 競爭趨勢
    • 市場佔有率分析
    • 市場策略
    • 案例研究
  • 波特五力分析模式
  • 主要的購買標準
  • 策略性建議
  • 策略性結論

第3章 市場決策因素

  • 推動市場的要素
  • 推動市場的要素
  • 市場課題
  • 市場機會
  • 親市場
  • 競爭市場
  • 替代市場

第4章 市場區隔

  • 各類型

第5章 各地區分析

  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第6章 企業簡介

  • ACTAVIS, INC.
  • BAYER AG
  • CHURCH & DWIGHT CO., INC.
  • COOPERSURGICAL, INC.
  • HLL LIFECARE LIMITED
  • MANKIND
  • MAYER LABORATORIES, INC.
  • MERCK & CO., INC.
  • PACE PHARMACEUTICALS, INC.
  • PFIZER, INC.
  • RECKITT BENCKISER PLC
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.
  • THE FEMALE HEALTH COMPANY
  • TTK-LIG

圖表

目錄
Product Code: HPH-2980916

The global contraceptive market is mainly driven by various factors such as growing prevalence of sexually transmitted diseases and the growing need to control the rising population. The launch of new products with enhanced efficacy is expected to drive the contraceptive market over the forecast period. The global contraceptive market is estimated to grow with a CAGR of 4.3% during 2016-2022. These drugs or devices interfere with the normal process of ovulation, fertilization and implantation to prevent the pregnancy; and also, inhibits sexually transmitted diseases. There are a number of birth control drugs and devices available in the market that act at different point in the process.

The global contraceptive market is majorly driven by various factors such as growing prevalence of sexually transmitted diseases (STDs), such as HIV and syphilis with a large chunk of population suffering from such diseases around the world, with the number is increasing every day. The initiatives taken by various governments and NGOs across the globe to encourage and promote the usage of contraceptives drugs and devices with the primary focus on reducing the rate of population growth; and also, to control the spread of various STDs is the key factor that has provided impetus to the growth of this market. Moreover, major companies introducing new products with superior effectiveness is also likely to drive the contraceptive market over the forecast period. However, various moral, social and ethical issues are some of the major concerns that are limiting the use contraceptives in some regions like Middle-East. Furthermore, growing ubiquity of infertility among women and rising geriatric population are further expected to restrict the use of contraceptives, thus curbing the market growth.

The global contraceptive market is segmented into two categories namely, drugs and devices. The contraceptive drugs can be further categorized on the basis of its application into three different forms i.e. pills, injectable and patches. Injectable are projected to be segment with the highest growth owing to lesser side effects of injectable over the oral contraceptives and lesser failure rates. Still, the oral drugs or pills are the most conventional and dominated the global contraceptive drugs market share in 2014. On the basis of product type, the market is segmented into contraceptive drugs and contraceptive devices; of which Contraceptive drugs segment dominated the market share, in terms of revenue in 2014. As contraceptive drugs are readily available and easy to use, drugs are more favored over the devices. The contraceptive devices market include both male and female contraceptive devices. In 2015, contraceptive devices accounted for $9,395 million and it is anticipated to witness a CAGR of 5.4% during the forecast period, which is attributed to the rising levels of awareness and the lesser side effects of devices over the contraceptive pills. The Companies are also trying for advancement in contraceptive devices to attract more new customers in the segment.

Table of Contents

1. INTRODUCTION

  • 1.1. EXECUTIVE SUMMARY
  • 1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW

  • 2.1. MARKET DEFINITION AND SCOPE
  • 2.2. KEY FINDINGS
  • 2.3. PARAMETRIC ANALYSIS
  • 2.4. KEY MARKET INSIGHTS
    • 2.4.1. TOP EMERGING COUNTRIES
    • 2.4.2. TOP REVENUE GENERATING SEGMENTS
    • 2.4.3. TOP GROWING MARKETS AND EMERGING TRENDS
  • 2.5. COMPETITIVE LANDSCAPE
    • 2.5.1. MARKET SHARE ANALYSIS
    • 2.5.2. TOP WINNING STRATEGIES
    • 2.5.3. CASE STUDIES: TOP COMPETITIVE MOVES
  • 2.6. PORTER'S FIVE FORCE MODEL
    • 2.6.1. THREAT OF NEW ENTRANTS
    • 2.6.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
    • 2.6.3. BARGAINING POWER OF BUYER
    • 2.6.4. BARGAINING POWER OF SUPPLIER
    • 2.6.5. INTENSITY OF COMPETITIVE RIVALRY
  • 2.7. KEY BUYING CRITERIA
  • 2.8. STRATEGIC RECOMMENDATION
  • 2.9. STRATEGIC CONCLUSIONS

3. MARKET DETERMINANTS

  • 3.1. MARKET DRIVERS
    • 3.1.1. IMPLEMENTATION OF VARIOUS FAVORABLE GOVERNMENT REGULATIONS TO INCREASE THE USE OF CONTRACEPTIVES
    • 3.1.2. VARIOUS GOVERNMENT INITIATIVES AND AWARENESS PROGRAMS TO PROMOTE THE USE OF CONTRACEPTIVES ACROSS THE GLOBE
  • 3.2. MARKET RESTRAINTS
    • 3.2.1. HIGH PREVALENCE RATE OF INFERTILITY AMONG WOMEN AND AGING POPULATION TO LIMIT THE USE OF CONTRACEPTIVE
    • 3.2.2. ETHICAL AND SOCIAL ISSUES TO RESTRICT THE USE OF CONTRACEPTIVES IN SOME REGIONS
  • 3.3. MARKET OPPORTUNITIES
    • 3.3.1. LARGE UNMET DEMAND OF CONTRACEPTIVE IN EMERGING ECONOMIES OF ASIA AND AFRICA
    • 3.3.2. PRESENCE OF STRONG PIPELINE PRODUCTS
  • 3.4. PARENT MARKET
  • 3.5. COMPETITORS MARKET
  • 3.6. ALTERNATIVE MARKET

4. MARKET SEGMENTATION

  • 4.1. GLOBAL CONTRACEPTIVE MARKET BY TYPE 2014-2022 ($ MILLION)
    • 4.1.1. GLOBAL CONTRACEPTIVE DRUGS MARKET 2014-2022 ($ MILLION)
      • 4.1.1.1.1. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET 2014-2022 ($ MILLION)
      • 4.1.1.1.2. GLOBAL CONTRACEPTIVE INJECTABLE MARKET 2014-2022 ($ MILLION)
      • 4.1.1.1.3. GLOBAL TOPICAL CONTRACEPTIVES MARKET 2014-2022 ($ MILLION)
    • 4.1.2. GLOBAL CONTRACEPTIVE DEVICES MARKET 2014-2022 ($ MILLION)
      • 4.1.2.1. GLOBAL MALE CONTRACEPTIVE DEVICES MARKET 2014-2022 ($ MILLION)
        • 4.1.2.1.1 GLOBAL MALE CONTRACEPTIVE DEVICES MALE CONDOMS MARKET 2014-2022 ($ MILLION)
      • 4.1.2.2. GLOBAL FEMALE CONTRACEPTIVE DEVICES MARKET 2014-2022 ($ MILLION)
        • 4.1.2.2.1. GLOBAL CONTRACEPTIVE DIAPHRAGMS MARKET 2014-2022 ($ MILLION)
        • 4.1.2.2.2. GLOBAL CONTRACEPTIVE SPONGES MARKET 2014-2022 ($ MILLION)
        • 4.1.2.2.3. GLOBAL CONTRACEPTIVE VAGINAL RINGS MARKET 2014-2022 ($ MILLION)
        • 4.1.2.2.4. GLOBAL INTRAUTERINE DEVICES MARKET 2014-2022 ($ MILLION)
        • 4.1.2.2.5. GLOBAL SUBDERMAL CONTRACEPTIVE IMPLANTS MARKET 2014-2022 ($ MILLION)
        • 4.1.2.2.6. GLOBAL NON-SURGICAL PERMANENT CONTRACEPTION DEVICES MARKET 2014-2022 ($ MILLION)

5. GEOGRAPHICAL ANALYSIS

  • 5.1. NORTH AMERICA CONTRACEPTIVE MARKET 2014-2022 ($ MILLION)
    • 5.1.1. UNITED STATES (U.S.) CONTRACEPTIVE MARKET 2014-2022 ($ MILLION)
    • 5.1.2. CANADA CONTRACEPTIVE MARKET 2014-2022 ($ MILLION)
  • 5.2. EUROPE CONTRACEPTIVE MARKET 2014-2022 ($ MILLION)
    • 5.2.1. UNITED KINGDOM (UK) CONTRACEPTIVE MARKET 2014-2022 ($ MILLION)
    • 5.2.2. FRANCE CONTRACEPTIVE MARKET 2014-2022 ($ MILLION)
    • 5.2.3. GERMANY CONTRACEPTIVE MARKET 2014-2022 ($ MILLION)
    • 5.2.4. SPAIN CONTRACEPTIVE MARKET 2014-2022 ($ MILLION)
    • 5.2.5. ITALY CONTRACEPTIVE MARKET 2014-2022 ($ MILLION)
    • 5.2.6. ROE CONTRACEPTIVE MARKET 2014-2022 ($ MILLION)
  • 5.3. ASIA PACIFIC CONTRACEPTIVE MARKET 2014-2022 ($ MILLION)
    • 5.3.1. INDIA CONTRACEPTIVE MARKET 2014-2022 ($ MILLION)
    • 5.3.2. CHINA CONTRACEPTIVE MARKET 2014-2022 ($ MILLION)
    • 5.3.3. JAPAN CONTRACEPTIVE MARKET 2014-2022 ($ MILLION)
    • 5.3.4. ROAPAC CONTRACEPTIVE MARKET 2014-2022 ($ MILLION)
  • 5.4. REST OF THE WORLD CONTRACEPTIVE MARKET 2014-2022 ($ MILLION)
    • 5.4.1. LATIN AMERICA CONTRACEPTIVE MARKET 2014-2022 ($ MILLION)
    • 5.4.2. MENA CONTRACEPTIVE MARKET 2014-2022 ($ MILLION)
    • 5.4.3. AFRICA CONTRACEPTIVE MARKET 2014-2022 ($ MILLION)

6. COMPANY PROFILES

  • 1. ACTAVIS, INC.
  • 2. BAYER AG
  • 3. CHURCH & DWIGHT CO., INC.
  • 4. COOPERSURGICAL, INC.
  • 5. HLL LIFECARE LIMITED
  • 6. MANKIND
  • 7. MAYER LABORATORIES, INC.
  • 8. MERCK & CO., INC.
  • 9. PACE PHARMACEUTICALS, INC.
  • 10. PFIZER, INC.
  • 11. RECKITT BENCKISER PLC
  • 12. TEVA PHARMACEUTICAL INDUSTRIES LTD.
  • 13. THE FEMALE HEALTH COMPANY
  • 14. TTK-LIG

LIST OF TABLES

  • 1. GLOBAL CONTRACEPTIVE DRUGS MARKET 2014-2022 ($ MILLION)
  • 2. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET 2014-2022 ($ MILLION)
  • 3. GLOBAL CONTRACEPTIVE INJECTABLE MARKET 2014-2022 ($ MILLION)
  • 4. GLOBAL TOPICAL CONTRACEPTIVES MARKET 2014-2022 ($ MILLION)
  • 5. GLOBAL CONTRACEPTIVE DEVICES MARKET 2014-2022 ($ MILLION)
  • 6. GLOBAL MALE CONTRACEPTIVE DEVICES (MALE CONDOMS) MARKET 2014-2022 ($ MILLION)
  • 7. GLOBAL FEMALE CONTRACEPTIVE DEVICES MARKET 2014-2022 ($ MILLION)
  • 8. GLOBAL CONTRACEPTIVE DIAPHRAGMS MARKET 2014-2022 ($ MILLION)
  • 9. GLOBAL CONTRACEPTIVE SPONGES MARKET 2014-2022 ($ MILLION)
  • 10. GLOBAL CONTRACEPTIVE VAGINAL RINGS MARKET 2014-2022 ($ MILLION)
  • 11. GLOBAL INTRAUTERINE DEVICES MARKET 2014-2022 ($ MILLION)
  • 12. GLOBAL SUBDERMAL CONTRACEPTIVE IMPLANTS MARKET 2014-2022 ($ MILLION)
  • 13. GLOBAL NON-SURGICAL PERMANENT CONTRACEPTION DEVICES MARKET 2014-2022 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL CONTRACEPTIVE MARKET SHARE 2014-2022 ($ MILLION)
  • 2. MARKET SHARE BY REGIONS
  • 3. UNITED STATES MARKET ESTIMATES AND FORECAST 2014-2022 ($ MILLION)
  • 4. CANADA MARKET ESTIMATES AND FORECAST 2014-2022 ($ MILLION)
  • 5. MEXICO MARKET ESTIMATES AND FORECAST 2014-2022 ($ MILLION)
  • 6. UK MARKET ESTIMATES AND FORECAST 2014-2022 ($ MILLION)
  • 7. FRANCE MARKET ESTIMATES AND FORECAST 2014-2022 ($ MILLION)
  • 8. GERMANY MARKET ESTIMATES AND FORECAST 2014-2022 ($ MILLION)
  • 9. APAC MARKET ESTIMATES AND FORECAST 2014-2022 ($ MILLION)
  • 10. CHINA MARKET ESTIMATES AND FORECAST 2014-2022 ($ MILLION)
  • 11. INDIA MARKET ESTIMATES AND FORECAST 2014-2022 ($ MILLION)
  • 12. MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2014-2022 ($ MILLION)
  • 13. CENTRAL & SOUTH AMERICA MARKET ESTIMATES AND FORECAST 2014-2022 ($ MILLION)
  • 14. BRAZIL MARKET ESTIMATES AND FORECAST 2014-2022 ($ MILLION)
Back to Top